Claris antibiotics recalled due to mold contamination

Another day, another recall: India-based Claris Lifesciences is recalling "to the user level" antibiotic and anti-nausea drugs following reports of floating matter in IV bags. The recalls follow by just a holiday weekend those of Blacksmith Brands' children's medications, deemed guilty by association for being made by McNeil at its plant in Fort Washington, PA--ground zero for the recent Children's Tylenol recalls.

Antibiotics metronidazole and ciprofloxacin, and anti-nausea drug ondansetron, are the recalled Claris drugs. The sterile injectables originated at the same Ahmedabad facility (one of the company's five manufacturing sites in the city) and on the same manufacturing line. One Claris customer reported white matter in a bag of metronidazole, which was identified as Cladosporium mold, according to a press report.

The drug recalls also affect Pfizer, Sagent Pharmaceuticals, BioSyent, and West-Ward Pharmaceuticals, which sell the drugs.

- here's the Claris recall
- see this press report
- here's more

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.